Zombified (senescent) cells contribute to aging; therapies aim to boost immune clearance
Emerging therapies target senescent “zombie” cells by killing them or helping macrophages clear them from aging tissues.
Key points
From Live Science’s report- Emerging treatments seek to reverse aging signs and reduce age-related disease risk.
- Zombie cells are senescent cells that refuse to die and inflame tissues.
- Senolytics drugs can kill senescent cells, lowering inflammation and improving function in mice.
- EP2 receptor on macrophages impairs clearance of senescent cells as we age.
- Blocking EP2 or boosting macrophage energy improves aging-related outcomes in studies.
Why it matters. These cells inflame tissues, while senolytics, EP2 blockade, and improved macrophage energy have improved aging-related outcomes in studies.
What to watch. Researchers will assess whether these approaches safely reverse aging signs and reduce age-related disease risk in people.
Coverage
Oldest first · UTCCoverage
Oldest first · UTCSourceLive ScienceUnited StatesLeanCenterCredibilityRatings: AllSides, MBFCRead at Live Science“Zombified cells may drive aging, and scientists are devising new ways to get rid of them”
Why it’s in the Brief
Ranked 10th of 10.
- Starting score
- 5.0
- Public-interest topic
- +1.0
- Public-interest terms in the text
- +1.25
- High-reliability sources
- +0.75
- Score
- 8.0
The ranking is the same for everyone.
Perspective mix. 1 center.RatingsAllSides and Media Bias/Fact CheckLean and credibility are curated from their public ratings.Unknown outlets stay unrated, never guessed.